您的位置: 首页 > 农业专利 > 详情页

USE OF FENFLURAMINE FORMULATION IN REDUCING NUMBER AND FREQUENCIES OF CONVULSIVE SEIZURES IN PATIENT POPULATIONS
专利权人:
ZOGENIX INTERNATIONAL LIMITED
发明人:
FARFEL, Gail,LOCK, Michael,GALER, Bradley S.,MORRISON, Glenn,BOYD, Brooks M.
申请号:
SG11202002743T
公开号:
SG11202002743TA
申请日:
2018.09.25
申请国别(地区):
SG
年份:
2020
代理人:
摘要:
A method of reducing convulsive seizure frequency in a human patient diagnosed with Dravet syndrome, comprising administering to the patient a therapeutically effective dose of fenfluramine or a pharmaceutically acceptable salt, base, acid or amine thereof, and repeating the administering over a period of days until the patient exhibits a significant reduction (e.g., 40% or greater) from baseline in convulsive seizure frequency. In some embodiments of the method, convulsive seizures are completely eliminated for 10 days or more, 20 days or more, 30 days or more, 50 days or more, 100 days or more.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充